Area of research
Rheumatology · Pharmacology
Research interest
Research interests include Medicine, Internal medicine, Omalizumab, Placebo, Angioedema, and Clinical endpoint.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase-3 Pivotal Trials
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study
Ligelizumab for Chronic Spontaneous Urticaria